Notice: 函数 WP_Styles::add 的调用方法不正确。 The style with the handle "storefront-woocommerce-style" was enqueued with dependencies that are not registered: storefront-style. 请查阅调试 WordPress来获取更多信息。 (这个消息是在 6.9.1 版本添加的。) in /wordpress/wp-includes/functions.php on line 6260

KC-3086

293T-CD79a Cell Line

Home » Cell Lines » 293T-CD79a Cell Line

Background of 293T-CD79a Cell Line

After the antigen binds to the BCR, the CD79A/CD79B heterodimer can transmit activation signals, triggering the proliferation, differentiation and antibody production of B cells. The cytoplasmic region of CD79A contains the immunoreceptor tyrosine-based activation motif (ITAM), which is a key structure for signal transduction. The important regulatory role of CD79A in B cell function is involved in the processes of antigen recognition, activation, proliferation and differentiation of B cells. The expression of CD79A is also associated with the occurrence and development of certain B cell tumors, such as B-cell acute lymphoblastic leukemia (B-ALL).

Specifications

Catalog Number:
KC-3086
Cell Line Name:
293T-CD79a Cell Line
Clone Number
Host Cell Line:
293T
Description:
Stable HEK293T cell line expressing exogenous human CD79a gene
Quantity:
Two vials of frozen cells (over than 5×106)
Stability:
Stable in culture over a minimum of 10 passages
Application:
Drug screening and biological assays
Freezing Medium:
70% DMEM + 20% FBS + 10% DMSO
Propagation Medium:
DMEM + 10% FBS + 1ug/ml Puromycin
Selection Marker:
Puromycin
Morphology:
Fibroblastoid cells growing as a monolayer
Subculture:
Split saturated culture 1:4-1:8 every 2-3 days; seed out at about 1-3 × 105 cells/mL
Incubation:
37 °C with 5% CO2
Storage:
Liquid nitrogen immediately upon receiving
Doubling Time:
Approximately 30 hours
Mycoplasma Status:
Negative
In Vivo Validation:
NA

Cell Line Generation

293T human CD79a cell line was generated using a lentiviral vector expressing the human CD79a sequence.

Characterization

Figure 1: Characterization of CD79a overexpression in 293T-CD79a stable clones using FACS.

Figure 2: Characterization of endogenous human CD79a expression in 293T using FACS.

Cell Resuscitation

1. Prewarm culture medium (DMEM supplemented with 10% FBS and 1μg/mL puromycin)in a 37°C water bath. 2. Thaw the frozen vial in a 37°C water bath for 1-2 minutes. 3. Transfer the vial into biosafety cabinet, and wipe the surface with 70% ethanol. 4. Unscrew the top of the vial and transfer the cell suspension gently into a sterile centrifuge tube containing 9.0mL complete culture medium. 5. Spin at ~ 125 × g for 5-7 minutes at room temperature, and discard the supernatant without disturbing the pellet. 6. Resuspend cell pellet with the appropriate volume of complete medium and transfer the cell suspension into a T25 culture flask. 7. Incubate the flask at 37°C, 5% CO2 incubator. 8. Split saturated culture 1:4-1:8 every 2-3 days; seed out at about 1-3 × 105 cells/mL.

Cell Freezing

1. Prepare the freezing medium (70% DMEM + 20% FBS + 10% DMSO) fresh immediately before use. 2. Keep the freezing medium on ice and label cryovials. 3. Transfer cells to a sterile, conical centrifuge tube, and count the cells. 4. Centrifuge the cells at 250×g for 5 minutes at room temperature and carefully aspirate off the medium. 5. Resuspend the cells at a density of at least 3×106 cells/mL in chilled freezing medium. 6. Aliquot 1 mL of the cell suspension into each cryovial. 7. Freeze cells in the CoolCell freezing container overnight in a -80°C freezer. 8. Transfer vials to liquid nitrogen for long-term storage

References

1.Lenk L, Carlet M, Vogiatzi F, Spory L, Winterberg D, Cousins A, Vossen-Gajcy M, Ibruli O, Vokuhl C, Cario G, El Ayoubi O, Kramer L, Ritgen M, Brüggemann M, Häsler R, Schrappe M, Fuhrmann S, Halsey C, Jeremias I, Hobeika E, Jumaa H, Alsadeq A, Schewe DM. CD79a promotes CNS-infiltration and leukemia engraftment in pediatric Bcell precursor acute lymphoblastic leukemia. Commun Biol. 2021 Jan 15;4(1):73. 2.Hashimoto M, Yamashita Y, Mori N. Immunohistochemical detection of CD79a expression in precursor T cell lymphoblastic lymphoma/leukaemias. J Pathol. 2002 Jul;197(3):341-7. 3.Huse K, Bai B, Hilden VI, Bollum LK, Våtsveen TK, Munthe LA, Smeland EB, Irish JM, Wälchli S, Myklebust JH. Mechanism of CD79A and CD79B Support for IgM+ B Cell Fitness through B Cell Receptor Surface Expression. J Immunol. 2022 Nov 15;209(10):2042-2053.